Vimarsana
Biggest News Aggregation in the World

Project Bioshield News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Project Bioshield. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Project Bioshield Today - Breaking & Trending Today

Soligenix Announces Reverse Stock Split - Vimarsana News

Soligenix Announces Reverse Stock Split

/PRNewswire/ -- Soligenix, Inc. (NASDAQ: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

SOLIGENIX, INC.: Soligenix Announces Reverse Stock Split - Vimarsana News

SOLIGENIX, INC.: Soligenix Announces Reverse Stock Split

Common Stock Will Begin Trading on Split-Adjusted Basis on June 6, 2024 PRINCETON, N.J., May 31, 2024 /PRNewswire/ -- Soligenix, Inc. (NASDAQ: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical

Soligenix Encourages Stockholders to Vote their Shares at the Annual Meeting - Vimarsana News

Soligenix Encourages Stockholders to Vote their Shares at the Annual Meeting

Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, encourages its eligible stockholders to vote their...

Soligenix Encourages Stockholders to Vote "FOR" Reverse Stock Split - Soligenix (NASDAQ:SNGX) - Vimarsana News

Soligenix Encourages Stockholders to Vote "FOR" Reverse Stock Split - Soligenix (NASDAQ:SNGX)

Most shareholders can vote by calling 1-833-782-7145 PRINCETON, N.J., May 23, 2024 /PRNewswire/ -- Soligenix, Inc. (NASDAQ:SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing

SuVax™ and MarVax™ Thermostable Vaccine Platform to be Presented at the Vaccine Technology IX Conference - Vimarsana News

SuVax™ and MarVax™ Thermostable Vaccine Platform to be Presented at the Vaccine Technology IX Conference

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...